Clinical Trial Update: A Study of CM310 in Subjects With Moderate to Severe Asthma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for CM310 in moderate to severe asthma (Phase 2/Phase 3) indicating ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CM310

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Moderate to Severe Asthma | Phase 2, Phase 3 | Status: RECRUITING